Ashland Inc (AHT.SG)
| Previous close | 91.00 |
| Open | 90.00 |
| Bid | 90.00 x 0 |
| Ask | 90.50 x 0 |
| Day's range | 90.00 - 90.00 |
| 52-week range | 65.50 - 91.50 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Ashland Board appoints Ashish K. Kulkarni as new director
WILMINGTON, Del., May 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is announcing the appointment of Ashish K. Kulkarni to its Board of Directors. Kulkarni is the CEO of Kebotix, a startup company focused on commercializing artificial intelligence methods into new material commercialization. He is the former executive vice president and chief innovation officer, GAF, former chief technology and innovation officer, Avantor and former chief technology and innovation officer, Celanese Corpo
- GlobeNewswire
Ashland board authorizes quarterly dividend
WILMINGTON, Del., May 07, 2024 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.405 cents per share on the company's common stock which represents a five percent increase from the previous quarter. The dividend is payable on June 15, 2024, to stockholders of record at the close of business on June 1, 2024. As of April 30, 2024, there were 50,128,349 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE: ASH
- Business Wire
Turnspire Capital Partners to Acquire Ashland Nutraceuticals Business
NEW YORK, May 07, 2024--Turnspire Capital Partners LLC ("Turnspire") announced today that an affiliate has signed a definitive agreement to acquire the nutraceuticals business of Ashland Inc. (NYSE: ASH) ("Ashland Nutraceuticals" or the "Business").
